7-fluoro-4-oxo-N-(1-(2-oxo-3,5,6,7-tetrahydro-2H-indeno[5,6-d]oxazol-5-yl)piperidin-4-yl)-4H-chromene-2-carboxamide

ID: ALA384111

Chembl Id: CHEMBL384111

PubChem CID: 44417897

Max Phase: Preclinical

Molecular Formula: C25H22FN3O5

Molecular Weight: 463.47

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(NC1CCN(C2CCc3cc4oc(=O)[nH]c4cc32)CC1)c1cc(=O)c2ccc(F)cc2o1

Standard InChI:  InChI=1S/C25H22FN3O5/c26-14-2-3-16-20(30)12-23(33-21(16)10-14)24(31)27-15-5-7-29(8-6-15)19-4-1-13-9-22-18(11-17(13)19)28-25(32)34-22/h2-3,9-12,15,19H,1,4-8H2,(H,27,31)(H,28,32)

Standard InChI Key:  ZZUJEMNDSKZYLV-UHFFFAOYSA-N

Associated Targets(Human)

KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCHR1 Tchem Melanin-concentrating hormone receptor 1 (5587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCHR2 Tchem Melanin-concentrating hormone receptor (55 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 463.47Molecular Weight (Monoisotopic): 463.1543AlogP: 3.25#Rotatable Bonds: 3
Polar Surface Area: 108.55Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 9.56CX Basic pKa: 7.54CX LogP: 2.51CX LogD: 2.13
Aromatic Rings: 4Heavy Atoms: 34QED Weighted: 0.48Np Likeness Score: -0.62

References

1. Souers AJ, Iyengar RR, Judd AS, Beno DW, Gao J, Zhao G, Brune ME, Napier JJ, Mulhern MM, Lynch JK, Freeman JC, Wodka D, Chen CJ, Falls HD, Brodjian S, Dayton BD, Diaz GJ, Bush EN, Shapiro R, Droz BA, Knourek-Segel V, Hernandez LE, Marsh KC, Reilly RM, Sham HL, Collins CA, Kym PR..  (2007)  Constrained 7-fluorocarboxychromone-4-aminopiperidine based Melanin-concentrating hormone receptor 1 antagonists: the effects of chirality on substituted indan-1-ylamines.,  17  (4): [PMID:17188866] [10.1016/j.bmcl.2006.11.061]

Source